PT1222921E - Composicoes farmaceuticas de tizoxanida e nitazoxanida - Google Patents

Composicoes farmaceuticas de tizoxanida e nitazoxanida

Info

Publication number
PT1222921E
PT1222921E PT02002887T PT02002887T PT1222921E PT 1222921 E PT1222921 E PT 1222921E PT 02002887 T PT02002887 T PT 02002887T PT 02002887 T PT02002887 T PT 02002887T PT 1222921 E PT1222921 E PT 1222921E
Authority
PT
Portugal
Prior art keywords
tizoxanide
nitazoxanide
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
PT02002887T
Other languages
English (en)
Inventor
Rossignol Jean-Francois
Original Assignee
Romark Lab Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1222921(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Application filed by Romark Lab Lc filed Critical Romark Lab Lc
Publication of PT1222921E publication Critical patent/PT1222921E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PT02002887T 1997-05-07 1998-05-06 Composicoes farmaceuticas de tizoxanida e nitazoxanida PT1222921E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (1)

Publication Number Publication Date
PT1222921E true PT1222921E (pt) 2005-02-28

Family

ID=27420362

Family Applications (2)

Application Number Title Priority Date Filing Date
PT02002887T PT1222921E (pt) 1997-05-07 1998-05-06 Composicoes farmaceuticas de tizoxanida e nitazoxanida
PT98920285T PT1005342E (pt) 1997-05-07 1998-05-06 Composicoes farmaceuticas de tizoxanida e nitazoxanida

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT98920285T PT1005342E (pt) 1997-05-07 1998-05-06 Composicoes farmaceuticas de tizoxanida e nitazoxanida

Country Status (35)

Country Link
EP (2) EP1222921B1 (pt)
JP (1) JP3739802B2 (pt)
KR (2) KR100426657B1 (pt)
CN (2) CN1158074C (pt)
AP (1) AP1103A (pt)
AR (1) AR057242A2 (pt)
AT (2) ATE228839T1 (pt)
AU (1) AU740022B2 (pt)
BG (2) BG109365A (pt)
BR (1) BR9808722A (pt)
CA (2) CA2418634C (pt)
CZ (2) CZ298270B6 (pt)
DE (2) DE69809928T2 (pt)
DK (2) DK1005342T3 (pt)
EA (2) EA002908B1 (pt)
EE (1) EE04870B1 (pt)
ES (2) ES2150404T3 (pt)
GE (1) GEP20032970B (pt)
HK (1) HK1025907A1 (pt)
HU (1) HU229641B1 (pt)
IL (2) IL132516A (pt)
IS (1) IS2087B (pt)
LV (1) LV12492B (pt)
ME (1) ME00530B (pt)
NO (2) NO313983B1 (pt)
NZ (2) NZ500149A (pt)
OA (1) OA11169A (pt)
PL (1) PL193275B1 (pt)
PT (2) PT1222921E (pt)
RO (1) RO120605B1 (pt)
SI (1) SI20149B (pt)
SK (2) SK283946B6 (pt)
TR (1) TR199902733T2 (pt)
UA (2) UA57079C2 (pt)
WO (1) WO1998050035A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
DK1976516T3 (da) 2006-01-09 2013-07-15 Romark Lab Lc Behandling af viral hepatitis
EP2395840B1 (en) * 2009-02-13 2020-04-15 Romark Laboratories, L.C. Controlled release pharmaceutical formulations of nitazoxanide
AU2010247816B2 (en) 2009-05-12 2015-12-17 Romark Laboratories L.C. Haloalkyl heteroaryl benzamide compounds
ES2914949T3 (es) 2009-06-26 2022-06-17 Romark Laboratories Lc Compuestos y métodos para tratar la gripe
BR112014018149B1 (pt) 2012-01-27 2020-09-29 Siegfried Rhein S.A. De C.V Composição farmacêutica de nitazoxanida
BR112017009651A2 (pt) * 2014-11-11 2017-12-19 Romark Laboratories Lc composto, composição farmacêutica, e, método para tratamento de uma infecção por protozoário intracelular, uma infecção viral ou um câncer.
CA3087898A1 (en) 2018-02-02 2019-08-08 Ripple Therapeutics Corporation Glass formulations comprising steroid dimers and uses thereof
CN115956083A (zh) 2020-05-01 2023-04-11 波纹疗法公司 异二聚体组合物及用于治疗眼部病症的方法
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Also Published As

Publication number Publication date
UA57079C2 (uk) 2003-06-16
DK1222921T3 (da) 2005-03-07
SK151199A3 (en) 2000-07-11
CN1158074C (zh) 2004-07-21
EP1222921A1 (en) 2002-07-17
EA002908B1 (ru) 2002-10-31
HU229641B1 (en) 2014-03-28
AU7289598A (en) 1998-11-27
ES2232687T3 (es) 2005-06-01
NZ500149A (en) 2001-11-30
SI20149A (sl) 2000-08-31
IS5223A (is) 1999-10-19
NO995406D0 (no) 1999-11-04
DE69827417T2 (de) 2005-10-27
LV12492A (en) 2000-06-20
TR199902733T2 (xx) 2000-03-21
NO20021832L (no) 2000-01-04
HUP0003330A2 (hu) 2001-05-28
JP2001503067A (ja) 2001-03-06
EP1005342B1 (en) 2002-12-04
EA002920B1 (ru) 2002-10-31
HUP0003330A3 (en) 2002-10-28
EP1222921B1 (en) 2004-11-03
CA2288003C (en) 2003-10-21
EE04870B1 (et) 2007-08-15
DE69809928D1 (de) 2003-01-16
CN100515420C (zh) 2009-07-22
JP3739802B2 (ja) 2006-01-25
UA74388C2 (uk) 2005-12-15
EA199901012A1 (ru) 2000-08-28
PT1005342E (pt) 2003-02-28
DE69827417D1 (de) 2004-12-09
NO995406L (no) 2000-01-04
KR100426657B1 (ko) 2004-04-13
AU740022B2 (en) 2001-10-25
EP1005342A1 (en) 2000-06-07
GEP20032970B (en) 2003-05-27
CZ391199A3 (cs) 2000-07-12
ES2150404T1 (es) 2000-12-01
IL132516A (en) 2003-12-10
IL155799A0 (en) 2003-12-23
IL155799A (en) 2004-08-31
RO120605B1 (ro) 2006-05-30
SK283947B6 (sk) 2004-05-04
CA2418634A1 (en) 1998-11-12
BG64973B1 (bg) 2006-11-30
CZ298270B6 (cs) 2007-08-08
CN1552322A (zh) 2004-12-08
ME00530B (me) 2011-10-10
AP9901675A0 (en) 1999-12-31
CA2418634C (en) 2004-10-26
PL193275B1 (pl) 2007-01-31
IS2087B (is) 2006-03-15
IL132516A0 (en) 2001-03-19
LV12492B (en) 2001-01-20
EP1005342A4 (en) 2001-02-07
PL336805A1 (en) 2000-07-17
EA200100956A1 (ru) 2002-02-28
SI20149B (en) 2001-08-31
CN1255060A (zh) 2000-05-31
NO335781B1 (no) 2015-02-16
WO1998050035A1 (en) 1998-11-12
OA11169A (en) 2003-04-25
DK1005342T3 (da) 2003-03-24
AP1103A (en) 2002-09-04
ATE228839T1 (de) 2002-12-15
ES2150404T3 (es) 2003-07-01
NZ513881A (en) 2002-10-25
EE9900578A (et) 2000-08-15
CZ298269B6 (cs) 2007-08-08
AR057242A2 (es) 2007-11-21
NO20021832D0 (no) 2002-04-18
DE69809928T2 (de) 2003-04-24
BR9808722A (pt) 2000-07-11
CA2288003A1 (en) 1998-11-12
BG109365A (en) 2006-08-31
KR20010020322A (ko) 2001-03-15
BG103958A (en) 2000-07-31
KR20040004544A (ko) 2004-01-13
ATE281166T1 (de) 2004-11-15
SK283946B6 (sk) 2004-05-04
NO313983B1 (no) 2003-01-13
KR100576646B1 (ko) 2006-05-08
HK1025907A1 (en) 2000-12-01

Similar Documents

Publication Publication Date Title
PT1066027E (pt) Composicao farmaceutica de topiramato
PT907364E (pt) Composicao farmaceutica de libertacao sustida
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
PT1005328E (pt) Composicao compreendendo particulas de budesonido cristalinas finamente divididas
BR9802130A (pt) Compostos triaromáticos composição farmacêutica composição cosmética e uso de uma composição cosmética
HUP9902655A3 (en) Pharmaceutical composition of hedgehog proteins and use thereof
LT99141A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
PT1140110E (pt) Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas
PT1222921E (pt) Composicoes farmaceuticas de tizoxanida e nitazoxanida
IS2515B (is) Lyfjasamsetningar
HUP9900251A3 (en) Pharmaceutical compositions containing hedgehog proteins and use of former compositions
NO994436D0 (no) Farmasöytiske sammensetninger
BR9505130A (pt) Composto e composiçao farmacêutica
BR9605220A (pt) Gonadotropinas e composiçao farmacêutica
BR1100391A (pt) Composto e composição farmacêutica
BR1101151A (pt) Compostos e composição farmacêutica
SE9703737D0 (sv) Pharmaceutical composition and use
ZA99887B (en) Pharmaceutical composition of hedgehog proteins and use thereof.
ZA995006B (en) Pharmaceutical composition of hedgehog proteins and use thereof.
BR1100838A (pt) Composto e composição farmacêutica
SE9803771D0 (sv) Pharmaceutical composition and use